Abagovomab
CAS No. 792921-10-9
Abagovomab ( —— )
产品货号. M36884 CAS No. 792921-10-9
Abagovomab (Anti-Human CA-125 Recombinant Antibody) 是一种小鼠单克隆抗独特型抗体,靶向肿瘤相关抗原 CA-125。Abagovomab 由小鼠杂交瘤细胞产生,可以模仿人的 TAA, CA-125。Abagovomab 还能够诱导卵巢癌 (oc) 的体液和细胞免疫反应。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥2752 | 有现货 |
|
| 5MG | ¥4538 | 有现货 |
|
| 10MG | ¥6323 | 有现货 |
|
| 25MG | ¥9306 | 有现货 |
|
| 50MG | ¥12434 | 有现货 |
|
| 100MG | ¥16601 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Abagovomab
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Abagovomab (Anti-Human CA-125 Recombinant Antibody) 是一种小鼠单克隆抗独特型抗体,靶向肿瘤相关抗原 CA-125。Abagovomab 由小鼠杂交瘤细胞产生,可以模仿人的 TAA, CA-125。Abagovomab 还能够诱导卵巢癌 (oc) 的体液和细胞免疫反应。
-
产品描述Abagovomab (Anti-Human CA-125 Recombinant Antibody) is a murine monoclonal anti-idiotypic antibody, against the tumor-associated antigen, CA-125. Abagovomab is generated by a mouse hybridoma, can imitate the human TAA, CA-125. Abagovomab can elicit humoral and cellular immune responses against ovarian cancer (oc).
-
体外实验——
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Others
-
研究领域——
-
适应症——
化学信息
-
CAS Number792921-10-9
-
分子量
-
分子式——
-
纯度>98% (HPLC)
-
溶解度——
-
SMILES——
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Pfisterer J, et al. The anti-idiotypic antibody abagovomab in patients with recurrent ovarian cancer. A phase I trial of the AGO-OVAR. Ann Oncol. 2006 Oct;17(10):1568-77.?
产品手册
关联产品
-
TS-011
TS-011是一种选择性20-羟基二十碳四烯酸合成抑制剂。
-
Licoflavonol
Licoflavonol is a novel natural inhibitor of Salmonella T3SS, could be a promising candidate for novel type of anti-virulence drugs, it exhibits a strong inhibitory effect on the secretion of the SPI-1 effector proteins via regulating the transcription of the SicA/InvF genes, and the transportation of the effector protein SipC.
-
Buforin
Buforin
021-51111890
购物车()
sales@molnova.cn

